Disparities in Opioid Treatment Access Remain for Women, Black and Hispanic People

This post was originally published on this site

Buprenorphine is a prescription approved by the Food and Drug Administration (FDA) that effectively treats opioid dependence or addiction. But women, as well as Black and Hispanic populations, do not have equal access to this potentially lifesaving medication, new Mayo Clinic research finds.